Pricing Log in Create free account

INVO Fertility, Inc (IVF) vs Nexalin Technology, Inc. (NXL)

INVO Fertility, Inc and Nexalin Technology, Inc. are both Medical Devices companies. INVO Fertility, Inc is the larger, with a market value of $2.6M against $1.7M — 1.5× the size. Nexalin Technology, Inc. grew revenue faster over the last twelve months: 24.3% against 13.8%. INVO Fertility, Inc has the higher net margin (−116.3% vs −4,138.5%) and the higher return on invested capital (−27.9% vs −1,108.8%). Across the 18 metrics below, INVO Fertility, Inc leads on 12 and Nexalin Technology, Inc. on 6.

Valuation

Metric IVF NXL Medical Devices median
P/E n/m n/m 24.94
P/S 0.60 4.77 2.66
P/B 0.28 0.68 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 0.19 0.16 2.76
Earnings yield (2,070.09%) (980.57%) (12.66%)
Free cash flow yield (106.94%) (612.33%) (7.18%)

Profitability

Metric IVF NXL Medical Devices median
Gross margin 35.28% 86.14% 57.76%
Operating margin (78.72%) (4,201.66%) (14.84%)
Net margin (116.30%) (4,138.49%) (14.45%)
Free cash flow margin (63.97%) (2,917.96%) (5.70%)
Return on equity (203.65%) (240.25%) (10.56%)
Return on assets (38.79%) (187.89%) (17.26%)
Return on invested capital (27.92%) (1,108.82%) (5.22%)

Growth

Metric IVF NXL Medical Devices median
Revenue growth (TTM) 13.76% 24.26% 10.41%
EPS growth (last fiscal year) 94.33% 39.76% 28.17%
Revenue growth, 5-year CAGR 45.83% 4.42% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IVF NXL Medical Devices median
Debt to equity 0.03 0.00 0.04
Current ratio 0.71 1.25 2.67
Net debt to EBITDA 0.25 0.44 0.54

Dividend

Metric IVF NXL Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric IVF NXL Medical Devices median
Market cap 2.55m 1.69m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack